- Email: [email protected]
Subject index volume 69 (1996)
European Journal of Obstetrics & Gynecology and Reproductive Biology 69 (1996) 151
ELSEVIER
.
.
.
GYNECOLOGY .
.
.
Subject index Volume 69 (1996) Active management 69, 19 Amniotic fluid 69, 91 Antenatal 69, 69 Anti-AFP monoclonal antibody Antisperm antibodies 69, 129
69, 77
Biochemical 69, 69 Bone turnover 69, 109 Cervix dysplasia 69, 125 Chronic inflammation 69, 141 Clinical effect 69, 31 Colposcopy 69, 125 Complication of surgery 69, 141 Convulsion 69, 61 Corticosteroid therapy 69, 129 Counselling 69, 69 Cytomegalovirus 69, 91 Developing countries 69, 25 Diagnosis of PROM 69, 77 District health systems 69, 5 Dopamine 69, 61 Down's syndrome 69, 69 Drug quality 69, 25 Drug stability 69, 25 Eclampsia 69, 61 Endocervix 69, 125 Endometrial ablation 69, 103 Endometrium 69, 115 Epinephrine 69, 61 Ergometrine 69, 25 Ferrous sulfate 69, 121 Fetal infection 69, 91 Fetal membranes 69, 135 Germany
69, II
Hysteroscopy
69, 103
Improved AFP kit 69, 77 Intracervical prostaglandin 69, 97 In vitro fertilization 69, 73 Iron deficiency anemia 69, 121 Iron sucrose complex 69, 121
Mali 69, II Maternal mortality 69, 5, 47 Mean arterial blood pressure 69, 61 Medical Birth Register 69, 73 Menorraghia 69, 103 Nd-YAG laser 69, 103 Nigeria 69, II Nitric oxide 69, 135 Norepinephrine 69, 61 Oral (methyl)ergometrine 69, 31 Outcome 69, 129 Percutaneous estradiol 69, 109 Perinatal mortality 69, 11, 47, 73 Pharmacokinetics and pharmacodynamics Polymerase chain reaction 69, 91 Postmenopausal bleeding 69, 143 Postmenopause 69, 109 Post partum haemorrhage (PPH) 69, 19 Pregnancy 69, 83, 121 Pregnancy termination 69, 97 Prevention of PPH 69, 31 Primary reproductive health care 69, 41 Prospective follow-up study 69, 83 Prostaglandin E2 69, 135 Proteinuria 69, 61 Quinolones
69, 83
Safe Motherhood programmes 69, 47 Screening 69, 69 Seaweed 69, 125 Serology 69, 91 Sodium nitroprusside 69, 135 Specimen collector 69, 77 Stability 69, 31 Tamoxifen 69, 115 Tanzania 69, 41 Technology assessment 69, 73 Third stage 69, 19 Togo 69, 11 Traditional birth attendants (TBAs) Tropical climates 69, 25 Turnout 69~ 143 Ultrasonography
Laminaria 69, 125 L-Arginine 69, 135 Low birth weight 69, 73
69, 31
69, 115
Vagina 69, 141, 143 Vaginal misoprostol 69, 97
69, 47
.
°
.
.
.
.
.
.
.
.
.
.
.
.
.
.
ELSEVIER
.
.
.
GYNECOLOGY .
.
.
Subject index Volume 69 (1996) Active management 69, 19 Amniotic fluid 69, 91 Antenatal 69, 69 Anti-AFP monoclonal antibody Antisperm antibodies 69, 129
69, 77
Biochemical 69, 69 Bone turnover 69, 109 Cervix dysplasia 69, 125 Chronic inflammation 69, 141 Clinical effect 69, 31 Colposcopy 69, 125 Complication of surgery 69, 141 Convulsion 69, 61 Corticosteroid therapy 69, 129 Counselling 69, 69 Cytomegalovirus 69, 91 Developing countries 69, 25 Diagnosis of PROM 69, 77 District health systems 69, 5 Dopamine 69, 61 Down's syndrome 69, 69 Drug quality 69, 25 Drug stability 69, 25 Eclampsia 69, 61 Endocervix 69, 125 Endometrial ablation 69, 103 Endometrium 69, 115 Epinephrine 69, 61 Ergometrine 69, 25 Ferrous sulfate 69, 121 Fetal infection 69, 91 Fetal membranes 69, 135 Germany
69, II
Hysteroscopy
69, 103
Improved AFP kit 69, 77 Intracervical prostaglandin 69, 97 In vitro fertilization 69, 73 Iron deficiency anemia 69, 121 Iron sucrose complex 69, 121
Mali 69, II Maternal mortality 69, 5, 47 Mean arterial blood pressure 69, 61 Medical Birth Register 69, 73 Menorraghia 69, 103 Nd-YAG laser 69, 103 Nigeria 69, II Nitric oxide 69, 135 Norepinephrine 69, 61 Oral (methyl)ergometrine 69, 31 Outcome 69, 129 Percutaneous estradiol 69, 109 Perinatal mortality 69, 11, 47, 73 Pharmacokinetics and pharmacodynamics Polymerase chain reaction 69, 91 Postmenopausal bleeding 69, 143 Postmenopause 69, 109 Post partum haemorrhage (PPH) 69, 19 Pregnancy 69, 83, 121 Pregnancy termination 69, 97 Prevention of PPH 69, 31 Primary reproductive health care 69, 41 Prospective follow-up study 69, 83 Prostaglandin E2 69, 135 Proteinuria 69, 61 Quinolones
69, 83
Safe Motherhood programmes 69, 47 Screening 69, 69 Seaweed 69, 125 Serology 69, 91 Sodium nitroprusside 69, 135 Specimen collector 69, 77 Stability 69, 31 Tamoxifen 69, 115 Tanzania 69, 41 Technology assessment 69, 73 Third stage 69, 19 Togo 69, 11 Traditional birth attendants (TBAs) Tropical climates 69, 25 Turnout 69~ 143 Ultrasonography
Laminaria 69, 125 L-Arginine 69, 135 Low birth weight 69, 73
69, 31
69, 115
Vagina 69, 141, 143 Vaginal misoprostol 69, 97
69, 47
.
°
.
.
.
.
.
.
.
.
.
.
.
.
.
.